Company Analysis
Sign in

Bio-Techne Corp (TECH)

Nasdaq: TECH · Biological Products, (No Diagnostic Substances) · Minneapolis, MN · filing with the SEC since 1995
Full chart Alerts Compare
Grade6.3
◀ Past 7.2● Present 7.3▶ Future 4.2
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2026, as filed
Revenue$1.22B-0.4%
Net income$182M+147.9%
Earnings per share$1.16+152.2%
Operating cash flow$292M+1.6%
Cash$265M+63.2%
Debt$200M-42.2%
Shareholders’ equity$2.11B+9.9%
Shares, diluted157.0M-1.7%
Return on equity8.6%
The recordfrom its filings
Filings in 202677
Newest filingNov 12 · 10-Q/A
Annual reportAug 24, 2026
Quarterly reportNov 6, 2026
Next report due10-Q by Feb 9
Insider sales, 12 months$400,000
Insider buys, 12 months$0.00
Patents granted107
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $1.23BNet income $172MCash from operations $338Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
17181920212223242526
As filed, in USD. Nothing here is a forecast.

News

Nov 6, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton TECH · research, not advice